CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 76  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0987
LYS 10.0198
GLU 20.0244
LEU 30.0408
ARG 40.0521
CYS 50.0214
GLN 60.0293
CYS 70.0360
ILE 80.0851
LYS 90.0987
THR 100.0182
TYR 110.0162
SER 120.0227
LYS 130.0276
PRO 140.0100
PHE 150.0185
HIS 160.0271
PRO 170.0147
LYS 180.0428
PHE 190.0209
ILE 200.0061
LYS 210.0365
GLU 220.0226
LEU 230.0213
ARG 240.0178
VAL 250.0146
ILE 260.0107
GLU 270.0054
SER 280.0128
GLY 290.0616
PRO 300.0120
HIS 310.0194
CYS 320.0130
ALA 330.0290
ASN 340.0114
THR 350.0048
GLU 360.0126
ILE 370.0082
ILE 380.0153
VAL 390.0202
LYS 400.0132
LEU 410.0115
SER 420.0198
ASP 430.0249
GLY 440.0156
ARG 450.0113
GLU 460.0198
LEU 470.0190
CYS 480.0059
LEU 490.0129
ASP 500.0062
PRO 510.0204
LYS 520.0275
GLU 530.0161
ASN 540.0211
TRP 550.0043
VAL 560.0093
GLN 570.0168
ARG 580.0177
VAL 590.0033
VAL 600.0067
GLU 610.0060
LYS 620.0097
PHE 630.0071
LEU 640.0090
LYS 650.0258
ARG 660.0218
ALA 670.0331
GLU 680.0028
ASN 690.0144

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.